Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol for Poor Ovarian Responders
NCT04273256Phase 3Unknown
- Sponsor
- American University of Beirut Medical Center
- Start
- Feb 2020
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 3, randomised trial (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Number of retrieved oocytes at 4 months. Status: unknown.
Beyond the preview
Go deeper on NCT04273256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273256.